China
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 4.30 B
|
Dec. 31, 2023 | USD 0.53 | 1.44% |
|
China |
|
2 |
USD 3.79 B
|
Dec. 31, 2023 | USD 2.59 | 1.33% |
|
China |
|
3 |
USD 2.00 B
|
Dec. 31, 2023 | USD 6.95 | 4.11% |
|
China |
|
4 |
USD 1.99 B
|
Dec. 31, 2023 | USD 32.18 | 1.97% |
|
China |
|
5 |
USD 1.54 B
|
Dec. 31, 2023 | USD 1.58 | 1.46% |
|
China |
|
6 |
USD 1.37 B
|
Dec. 31, 2023 | USD 3.45 | 3.36% |
|
China |
|
7 |
USD 1.20 B
|
Dec. 31, 2023 | USD 0.56 | 0.44% |
|
China |
|
8 |
USD 1.06 B
|
Dec. 31, 2023 | USD 1.71 | 1.65% |
|
China |
|
9 |
USD 972.07 M
|
Dec. 31, 2023 | USD 0.25 | 2.80% |
|
China |
|
10 |
USD 913.57 M
|
Dec. 31, 2023 | USD 2.27 | 3.13% |
|
China |
|
11 |
USD 858.60 M
|
Dec. 31, 2023 | USD 12.91 | 2.15% |
|
China |
|
12 |
USD 858.20 M
|
Dec. 31, 2023 | USD 1.73 | 3.02% |
|
China |
|
13 |
USD 780.37 M
|
Dec. 31, 2023 | USD 6.04 | 3.46% |
|
China |
|
14 |
USD 774.91 M
|
Dec. 31, 2023 | USD 2.26 | 4.12% |
|
China |
|
15 |
USD 736.13 M
|
Dec. 31, 2023 | USD 1.32 | 0.63% |
|
China |
|
16 |
USD 723.80 M
|
Dec. 31, 2023 | USD 0.67 | 0.94% |
|
China |
|
17 |
USD 716.00 M
|
Dec. 31, 2023 | USD 0.67 | 1.67% |
|
China |
|
18 |
USD 706.11 M
|
Dec. 31, 2023 | USD 1.47 | 0.94% |
|
China |
|
19 |
USD 684.22 M
|
Dec. 31, 2023 | USD 3.86 | 1.55% |
|
China |
|
20 |
USD 660.32 M
|
Dec. 31, 2023 | USD 5.92 | 1.98% |
|
China |
|
21 |
USD 650.91 M
|
Dec. 31, 2023 | USD 7.83 | 2.23% |
|
China |
|
22 |
USD 642.07 M
|
Dec. 31, 2023 | USD 2.91 | 1.87% |
|
China |
|
23 |
USD 618.40 M
|
Dec. 31, 2023 | USD 4.53 | 2.64% |
|
China |
|
24 |
USD 591.46 M
|
Dec. 31, 2023 | USD 2.14 | 2.31% |
|
China |
|
25 |
USD 577.22 M
|
Dec. 31, 2023 | USD 5.16 | 2.25% |
|
China |
|
26 |
USD 567.91 M
|
Dec. 31, 2023 | USD 3.66 | 2.21% |
|
China |
|
27 |
USD 541.84 M
|
Dec. 31, 2023 | USD 3.33 | 0.92% |
|
China |
|
28 |
USD 509.50 M
|
Dec. 31, 2023 | USD 3.86 | 1.95% |
|
China |
|
29 |
USD 500.56 M
|
Dec. 31, 2023 | USD 0.54 | 1.42% |
|
China |
|
30 |
USD 494.19 M
|
Dec. 31, 2023 | USD 28.52 | 2.04% |
|
China |
|
31 |
USD 480.85 M
|
Dec. 31, 2023 | USD 0.61 | 1.47% |
|
China |
|
32 |
USD 468.34 M
|
Dec. 31, 2023 | USD 3.31 | 1.16% |
|
China |
|
33 |
USD 444.07 M
|
Dec. 31, 2023 | USD 4.81 | 3.11% |
|
China |
|
34 |
USD 442.50 M
|
Dec. 31, 2023 | USD 1.93 | 2.10% |
|
China |
|
35 |
USD 429.94 M
|
Dec. 31, 2023 | USD 10.09 | 5.71% |
|
China |
|
36 |
USD 415.12 M
|
Dec. 31, 2023 | USD 1.70 | 5.22% |
|
China |
|
37 |
USD 412.73 M
|
Dec. 31, 2023 | USD 3.65 | 3.06% |
|
China |
|
38 |
USD 411.01 M
|
Dec. 31, 2023 | USD 2.19 | 4.03% |
|
China |
|
39 |
USD 398.03 M
|
Dec. 31, 2023 | USD 4.26 | 1.90% |
|
China |
|
40 |
USD 387.14 M
|
Dec. 31, 2023 | USD 0.70 | 2.41% |
|
China |
|
41 |
USD 376.28 M
|
Dec. 31, 2023 | USD 7.41 | 1.09% |
|
China |
|
42 |
USD 355.73 M
|
Dec. 31, 2023 | USD 0.74 | 1.21% |
|
China |
|
43 |
USD 350.40 M
|
Dec. 31, 2023 | USD 1.59 | 3.28% |
|
China |
|
44 |
USD 336.71 M
|
Dec. 31, 2023 | USD 2.17 | 2.25% |
|
China |
|
45 |
USD 333.42 M
|
Dec. 31, 2023 | USD 0.94 | 3.63% |
|
China |
|
46 |
USD 332.15 M
|
Dec. 31, 2023 | USD 1.49 | 3.42% |
|
China |
|
47 |
USD 322.08 M
|
Dec. 31, 2023 | USD 2.18 | 1.66% |
|
China |
|
48 |
USD 320.23 M
|
Dec. 31, 2023 | USD 1.47 | 2.19% |
|
China |
|
49 |
USD 313.37 M
|
Dec. 31, 2023 | USD 2.64 | 2.39% |
|
China |
|
50 |
USD 310.72 M
|
Dec. 31, 2023 | USD 0.61 | 2.08% |
|
China |
The Health Care company in China with the highest EBITDA is Fosun International Limited (HKSE: 0656.HK) at USD 4.30 B.
The Health Care company in China with the lowest EBITDA is MicroPort Scientific Corporation (HKSE: 0853.HK) at USD -382.54 M.
The top 10 Health Care companies in China by EBITDA are Fosun International Limited, Sinopharm Group Co. Ltd., WuXi AppTec Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shanghai Pharmaceuticals Holding Co., Ltd, Chongqing Zhifei Biological Products Co., Ltd., CSPC Pharmaceutical Group Limited, Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Inner Mongolia Baotou Steel Union Co., Ltd. and Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited.
The bottom 10 Health Care companies in China by EBITDA are MicroPort Scientific Corporation, Zai Lab Limited, Shanghai Junshi Biosciences Co., Ltd., AIM Vaccine Co., Ltd., Cutia Therapeutics, Genscript Biotech Corporation, CanSino Biologics Inc., Fujian Aonong Biological Technology Group Incorporation Limited, RemeGen Co., Ltd. and Hebei Changshan Biochemical Pharmaceutical Co., Ltd..